PORTAGE PHARMACEUTICALS
Portage Pharmaceuticals LTD. is developing innovative cell permeable peptide (CPP) therapies to normalize gene expression, restore protein function, and improve medical outcomes. The Company has spun out its lead asset, PPL-003, to ophthalmic indications and has licensed this CellPorter technology to EyGen, a new ophthalmic company.
PORTAGE PHARMACEUTICALS
Industry:
Biopharma Biotechnology Pharmaceutical
Address:
Toronto, Ontario, Canada
Country:
Canada
Status:
Active
Similar Organizations
BioSentinel Pharmaceuticals
BioSentinel develops innovative tools and reagents for the study of botulinum neurotoxin (BoNT).
Kato Pharmaceuticals
Kato Pharmaceuticals is a clinical stage Bio-pharmaceutical company dedicated to the development of novel therapies for pathologies.
Kyowa Pharmaceutical
Kyowa Pharmaceutical is developing and marketing a wide range of branded and generic formulations of drugs in Japan.
Tavec pharma
Tavec Pharmaceuticals is developing injectable therapies to treat cancers.